These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10446461)

  • 1. Infrequent mutations of the MET gene in sporadic breast tumours.
    Bièche I; Champème MH; Lidereau R
    Int J Cancer; 1999 Sep; 82(6):908-10. PubMed ID: 10446461
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of heterozygosity on 7q31 occurs early during breast tumorigenesis.
    Champème MH; Bièche I; Beuzelin M; Lidereau R
    Genes Chromosomes Cancer; 1995 Apr; 12(4):304-6. PubMed ID: 7539286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene structure of the human MET proto-oncogene.
    Duh FM; Scherer SW; Tsui LC; Lerman MI; Zbar B; Schmidt L
    Oncogene; 1997 Sep; 15(13):1583-6. PubMed ID: 9380410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
    Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
    Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.
    Blaugrund JE; Johns MM; Eby YJ; Ball DW; Baylin SB; Hruban RH; Sidransky D
    Hum Mol Genet; 1994 Oct; 3(10):1895-7. PubMed ID: 7849720
    [No Abstract]   [Full Text] [Related]  

  • 6. Exon structure and flanking intronic sequences of the human RET proto-oncogene.
    Ceccherini I; Bocciardi R; Luo Y; Pasini B; Hofstra R; Takahashi M; Romeo G
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1288-95. PubMed ID: 7902707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physical map of the human RET proto-oncogene.
    Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
    Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach.
    Nishizuka S; Tamura G; Terashima M; Satodate R
    Br J Cancer; 1997; 76(12):1567-71. PubMed ID: 9413943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET.
    Wullich B; Sattler HP; Fischer U; Meese E
    Anticancer Res; 1994; 14(2A):577-9. PubMed ID: 8017863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human breast cancer: genetic alterations in the MET gene region.
    Tougas L; Halwani F; Tremblay G; Sampalis J; Lin J; Park M; Jothy S
    Clin Invest Med; 1996 Aug; 19(4):222-30. PubMed ID: 8853570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
    Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
    Lin JC; Scherer SW; Tougas L; Traverso G; Tsui LC; Andrulis IL; Jothy S; Park M
    Oncogene; 1996 Nov; 13(9):2001-8. PubMed ID: 8934547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.
    Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A
    Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene.
    Glukhova L; Lavialle C; Fauvet D; Chudoba I; Danglot G; Angevin E; Bernheim A; Goguel AF
    Oncogene; 2000 Feb; 19(6):754-61. PubMed ID: 10698493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial Hirschsprung's disease.
    Guan T; Li JC; Li MJ; Tou JF
    World J Gastroenterol; 2005 Jan; 11(2):275-9. PubMed ID: 15633231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo mutation of the RET proto-oncogene in a patient with MEN 2A.
    Mulligan LM; Eng C; Healey CS; Ponder MA; Feldman GL; Li P; Jackson CE; Ponder BA
    Hum Mol Genet; 1994 Jun; 3(6):1007-8. PubMed ID: 7951212
    [No Abstract]   [Full Text] [Related]  

  • 20. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
    Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
    Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.